{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:02:31Z","timestamp":1793826151804,"version":"4.6.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004257","name":"Helse Vest","doi-asserted-by":"publisher","award":["F-11546"],"award-info":[{"award-number":["F-11546"]}],"id":[{"id":"10.13039\/501100004257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004257","name":"Helse Vest","doi-asserted-by":"publisher","award":["912233"],"award-info":[{"award-number":["912233"]}],"id":[{"id":"10.13039\/501100004257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018694","name":"HORIZON EUROPE Marie Sklodowska-Curie Actions","doi-asserted-by":"publisher","award":["842619-DIE_CKD"],"award-info":[{"award-number":["842619-DIE_CKD"]}],"id":[{"id":"10.13039\/100018694","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Bergen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Fabry disease (FD) is a rare lysosomal storage disorder caused by mutations in the GLA gene, resulting in reduced or lack of \u03b1-galactosidase A activity. This results in the accumulation of globotriaosylceramide (Gb3) and other glycosphingolipids in lysosomes causing cellular impairment and organ failures. While current therapies focus on reversing Gb3 accumulation, they do not address the altered cellular signaling in FD. Therefore, this study aims to explore Gb3-independent mechanisms of kidney damage in Fabry disease and identify potential biomarkers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>To investigate these mechanisms, we utilized a zebrafish (ZF) <jats:italic>gla<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup> mutant (MU) model. ZF naturally lack A4GALT gene and, therefore, cannot synthesize Gb3. We obtained kidney samples from both wild-type (WT) (n\u2009=\u20098) and MU (n\u2009=\u20098) ZF and conducted proteome profiling using untargeted mass spectrometry. Additionally, we examined mitochondria morphology and cristae morphology using electron microscopy. To assess oxidative stress, we measured total antioxidant activity. Finally, immunohistochemistry was conducted on kidney samples to validate specific proteins.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our proteomics analysis of renal tissues from zebrafish revealed downregulation of lysosome and mitochondrial-related proteins in <jats:italic>gla<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup> MU renal tissues, while energy-related pathways including carbon, glycolysis, and galactose metabolisms were disturbed. Moreover, we observed abnormal mitochondrial shape, disrupted cristae morphology, altered mitochondrial volume and lower antioxidant activity in <jats:italic>gla<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup> MU ZF.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These results suggest that the alterations observed at the proteome and mitochondrial level closely resemble well-known GLA mutation-related alterations in humans. Importantly, they also unveil novel Gb3-independent pathogenic mechanisms in Fabry disease. Understanding these mechanisms could potentially lead to the development of innovative drug screening approaches. Furthermore, the findings pave the way for identifying new clinical targets, offering new avenues for therapeutic interventions in Fabry disease. The zebrafish <jats:italic>gla<\/jats:italic><jats:sup><jats:italic>\u2212<\/jats:italic>\/\u2212<\/jats:sup> mutant model proves valuable in elucidating these mechanisms and may contribute significantly to advancing our knowledge of this disorder.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s12967-023-04475-y","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T08:01:56Z","timestamp":1693900916000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Proteomic analysis unveils Gb3-independent alterations and mitochondrial dysfunction in a gla\u2212\/\u2212 zebrafish model of Fabry disease"],"prefix":"10.1186","volume":"21","author":[{"given":"Hassan Osman Alhassan","family":"Elsaid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariell","family":"Rivedal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Skandalou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einar","family":"Svarstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"T\u00f8ndel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Even","family":"Birkeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8ystein","family":"Eikrem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janka","family":"Babickova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Marti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8842-534X","authenticated-orcid":false,"given":"Jessica","family":"Furriol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,5]]},"reference":[{"issue":"4","key":"4475_CR1","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/0006-291X(73)90609-8","volume":"53","author":"CA Mapes","year":"1973","unstructured":"Mapes CA, Sweeley CC. Galactosyl (alpha 1\u20134)galactosylceramide: galactosyl hydrolase activity in normal and Fabry plasma. Biochem Biophys Res Commun. 1973;53(4):1317\u201324.","journal-title":"Biochem Biophys Res Commun"},{"key":"4475_CR2","unstructured":"Desnick RJ, Ioannou YA, Eng CM. \u03b1-Galactosidase A Deficiency: Fabry Disease. In: Valle DL, Antonarakis S, Ballabio A, Beaudet AL, Mitchell GA, editors. The Online Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw-Hill Education; 2019."},{"issue":"9","key":"4475_CR3","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3390\/genes11091091","volume":"11","author":"T Levstek","year":"2020","unstructured":"Levstek T, Vujkovac B, Trebusak Podkrajsek K. Biomarkers of Fabry nephropathy: review and future perspective. Genes (Basel). 2020;11(9):1091.","journal-title":"Genes (Basel)."},{"issue":"1\u20132","key":"4475_CR4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ymgme.2021.07.006","volume":"134","author":"JM Domm","year":"2021","unstructured":"Domm JM, Wootton SK, Medin JA, West ML. Gene therapy for Fabry disease: progress, challenges, and outlooks on gene-editing. Mol Genet Metab. 2021;134(1\u20132):117\u201331.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"4475_CR5","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41467-021-21371-5","volume":"12","author":"A Khan","year":"2021","unstructured":"Khan A, Barber DL, Huang J, Rupar CA, Rip JW, Auray-Blais C, et al. Lentivirus-mediated gene therapy for Fabry disease. Nat Commun. 2021;12(1):1178.","journal-title":"Nat Commun"},{"issue":"1","key":"4475_CR6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1681\/ASN.2012030316","volume":"24","author":"C Tondel","year":"2013","unstructured":"Tondel C, Bostad L, Larsen KK, Hirth A, Vikse BE, Houge G, et al. Agalsidase benefits renal histology in young patients with Fabry disease. J Am Soc Nephrol. 2013;24(1):137\u201348.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"4475_CR7","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa1510198","volume":"375","author":"DP Germain","year":"2016","unstructured":"Germain DP, Hughes DA, Nicholls K, Bichet DG, Giugliani R, Wilcox WR, et al. Treatment of Fabry\u2019s disease with the pharmacologic chaperone migalastat. N Engl J Med. 2016;375(6):545\u201355.","journal-title":"N Engl J Med"},{"issue":"1","key":"4475_CR8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","volume":"345","author":"CM Eng","year":"2001","unstructured":"Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, et al. Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry\u2019s disease. N Engl J Med. 2001;345(1):9\u201316.","journal-title":"N Engl J Med"},{"key":"4475_CR9","volume":"24","author":"K Hongo","year":"2020","unstructured":"Hongo K, Harada T, Fukuro E, Kobayashi M, Ohashi T, Eto Y. Massive accumulation of globotriaosylceramide in various tissues from a Fabry patient with a high antibody titer against alpha-galactosidase A after 6 years of enzyme replacement therapy. Mol Genet Metab Rep. 2020;24: 100623.","journal-title":"Mol Genet Metab Rep"},{"issue":"5","key":"4475_CR10","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.33594\/000000077","volume":"52","author":"F Braun","year":"2019","unstructured":"Braun F, Blomberg L, Brodesser S, Liebau MC, Schermer B, Benzing T, et al. Enzyme replacement therapy clears Gb3 deposits from a podocyte cell culture model of Fabry disease but fails to restore altered cellular signaling. Cell Physiol Biochem. 2019;52(5):1139\u201350.","journal-title":"Cell Physiol Biochem"},{"issue":"4","key":"4475_CR11","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2215\/CJN.09480819","volume":"15","author":"E Svarstad","year":"2020","unstructured":"Svarstad E, Marti HP. The changing landscape of Fabry disease. Clin J Am Soc Nephrol. 2020;15(4):569\u201376.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"4475_CR12","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/gim.2016.55","volume":"18","author":"R Schiffmann","year":"2016","unstructured":"Schiffmann R, Fuller M, Clarke LA, Aerts JM. Is it Fabry disease? Genet Med. 2016;18(12):1181\u20135.","journal-title":"Genet Med"},{"issue":"4","key":"4475_CR13","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00428-007-0468-6","volume":"451","author":"H Askari","year":"2007","unstructured":"Askari H, Kaneski CR, Semino-Mora C, Desai P, Ang A, Kleiner DE, et al. Cellular and tissue localization of globotriaosylceramide in Fabry disease. Virchows Arch. 2007;451(4):823\u201334.","journal-title":"Virchows Arch"},{"issue":"4","key":"4475_CR14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/cge.12386","volume":"86","author":"A Pisani","year":"2014","unstructured":"Pisani A, Visciano B, Imbriaco M, Di Nuzzi A, Mancini A, Marchetiello C, et al. The kidney in Fabry\u2019s disease. Clin Genet. 2014;86(4):301\u20139.","journal-title":"Clin Genet"},{"issue":"3","key":"4475_CR15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ymgme.2018.06.004","volume":"124","author":"C Wanner","year":"2018","unstructured":"Wanner C, Arad M, Baron R, Burlina A, Elliott PM, Feldt-Rasmussen U, et al. European expert consensus statement on therapeutic goals in Fabry disease. Mol Genet Metab. 2018;124(3):189\u2013203.","journal-title":"Mol Genet Metab"},{"issue":"24","key":"4475_CR16","doi-asserted-by":"crossref","first-page":"13382","DOI":"10.1021\/acs.analchem.7b03609","volume":"89","author":"M Boutin","year":"2017","unstructured":"Boutin M, Menkovic I, Martineau T, Vaillancourt-Lavigueur V, Toupin A, Auray-Blais C. Separation and analysis of lactosylceramide, galabiosylceramide, and globotriaosylceramide by LC-MS\/MS in urine of Fabry disease patients. Anal Chem. 2017;89(24):13382\u201390.","journal-title":"Anal Chem"},{"issue":"3","key":"4475_CR17","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s12276-021-00571-5","volume":"53","author":"TY Choi","year":"2021","unstructured":"Choi TY, Choi TI, Lee YR, Choe SK, Kim CH. Zebrafish as an animal model for biomedical research. Exp Mol Med. 2021;53(3):310\u20137.","journal-title":"Exp Mol Med"},{"key":"4475_CR18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fmolb.2020.00082","volume":"7","author":"T Zhang","year":"2020","unstructured":"Zhang T, Peterson RT. Modeling lysosomal storage diseases in the zebrafish. Front Mol Biosci. 2020;7:82.","journal-title":"Front Mol Biosci"},{"issue":"23","key":"4475_CR19","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1093\/hmg\/ddv369","volume":"24","author":"M Keatinge","year":"2015","unstructured":"Keatinge M, Bui H, Menke A, Chen YC, Sokol AM, Bai Q, et al. Glucocerebrosidase 1 deficient Danio rerio mirror key pathological aspects of human Gaucher disease and provide evidence of early microglial activation preceding alpha-synuclein-independent neuronal cell death. Hum Mol Genet. 2015;24(23):6640\u201352.","journal-title":"Hum Mol Genet"},{"key":"4475_CR20","volume":"31","author":"HOA Elsaid","year":"2022","unstructured":"Elsaid HOA, Furriol J, Blomqvist M, Diswall M, Leh S, Gharbi N, et al. Reduced alpha-galactosidase A activity in zebrafish (Danio rerio) mirrors distinct features of Fabry nephropathy phenotype. Mol Genet Metab Rep. 2022;31: 100851.","journal-title":"Mol Genet Metab Rep"},{"issue":"3","key":"4475_CR21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2008.06.016","volume":"95","author":"JS Shen","year":"2008","unstructured":"Shen JS, Meng XL, Moore DF, Quirk JM, Shayman JA, Schiffmann R, et al. Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells. Mol Genet Metab. 2008;95(3):163\u20138.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"4475_CR22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2019.129437","volume":"1864","author":"JJ Miller","year":"2020","unstructured":"Miller JJ, Kanack AJ, Dahms NM. Progress in the understanding and treatment of Fabry disease. Biochim Biophys Acta Gen Subj. 2020;1864(1): 129437.","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"4475_CR23","doi-asserted-by":"crossref","unstructured":"\u017divn\u00e1 M, Dost\u00e1lov\u00e1 G, Bare\u0161ov\u00e1 V, Mu\u0161\u00e1lkov\u00e1 D, Kucha\u0159 L, Asfaw B, et al. AGAL misprocessing-induced ER stress and the unfolded protein response: lysosomal storage-independent mechanism of Fabry disease pathogenesis? bioRxiv. 2022:2022.09.27.509714.","DOI":"10.1101\/2022.09.27.509714"},{"key":"4475_CR24","volume":"33","author":"F Consolato","year":"2022","unstructured":"Consolato F, De Fusco M, Schaeffer C, Pieruzzi F, Scolari F, Gallieni M, et al. \u03b1-Gal A missense variants associated with Fabry disease can lead to ER stress and induction of the unfolded protein response. Mol Genet Metab Rep. 2022;33: 100926.","journal-title":"Mol Genet Metab Rep"},{"issue":"5","key":"4475_CR25","first-page":"384","volume":"10","author":"A Read","year":"2021","unstructured":"Read A, Schroder M. The unfolded protein response: an overview. Biology (Basel). 2021;10(5):384.","journal-title":"Biology (Basel)."},{"key":"4475_CR26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-4-431-54240-7_33","volume-title":"Handbook of glycosyltransferases and related genes","author":"K Furukawa","year":"2014","unstructured":"Furukawa K, Kondo Y, Furukawa K. UDP-Gal: lactosylceramide alpha 1,4-galactosyltransferase (A4GALT). In: Taniguchi N, Honke K, Fukuda M, Narimatsu H, Yamaguchi Y, Angata T, editors. Handbook of glycosyltransferases and related genes. Tokyo: Springer Japan; 2014. p. 141\u20137."},{"issue":"2","key":"4475_CR27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ijc.2910610220","volume":"61","author":"S Taga","year":"1995","unstructured":"Taga S, Mangeney M, Tursz T, Wiels J. Differential regulation of glycosphingolipid biosynthesis in phenotypically distinct Burkitt\u2019s lymphoma cell lines. Int J Cancer. 1995;61(2):261\u20137.","journal-title":"Int J Cancer"},{"issue":"2","key":"4475_CR28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1152\/japplphysiol.01096.2012","volume":"114","author":"M Picard","year":"2013","unstructured":"Picard M, White K, Turnbull DM. Mitochondrial morphology, topology, and membrane interactions in skeletal muscle: a quantitative three-dimensional electron microscopy study. J Appl Physiol. 2013;114(2):161\u201371.","journal-title":"J Appl Physiol"},{"issue":"9","key":"4475_CR29","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.3390\/cells10092177","volume":"10","author":"J Lam","year":"2021","unstructured":"Lam J, Katti P, Biete M, Mungai M, AshShareef S, Neikirk K, et al. A universal approach to analyzing transmission electron microscopy with ImageJ. Cells. 2021;10(9):2177.","journal-title":"Cells"},{"issue":"5","key":"4475_CR30","doi-asserted-by":"crossref","first-page":"E859","DOI":"10.1073\/pnas.1617288114","volume":"114","author":"V Eisner","year":"2017","unstructured":"Eisner V, Cupo RR, Gao E, Csordas G, Slovinsky WS, Paillard M, et al. Mitochondrial fusion dynamics is robust in the heart and depends on calcium oscillations and contractile activity. Proc Natl Acad Sci U S A. 2017;114(5):E859\u201368.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"4475_CR31","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.aaf.2017.04.004","volume":"2","author":"H Zhang","year":"2017","unstructured":"Zhang H, Wen W, Yan J. Application of immunohistochemistry technique in hydrobiological studies. Aquaculture Fisheries. 2017;2(3):140\u20134.","journal-title":"Aquaculture Fisheries"},{"issue":"9","key":"4475_CR32","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova S, Temu T, Sinitcyn P, Carlson A, Hein MY, Geiger T, et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods. 2016;13(9):731\u201340.","journal-title":"Nat Methods"},{"issue":"8","key":"4475_CR33","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge SX, Jung D, Yao R. ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics. 2020;36(8):2628\u20139.","journal-title":"Bioinformatics"},{"issue":"D1","key":"4475_CR34","doi-asserted-by":"crossref","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","volume":"49","author":"M Kanehisa","year":"2021","unstructured":"Kanehisa M, Furumichi M, Sato Y, Ishiguro-Watanabe M, Tanabe M. KEGG: integrating viruses and cellular organisms. Nucleic Acids Res. 2021;49(D1):D545\u201351.","journal-title":"Nucleic Acids Res"},{"issue":"14","key":"4475_CR35","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/bioinformatics\/btt285","volume":"29","author":"W Luo","year":"2013","unstructured":"Luo W, Brouwer C. Pathview: an R\/Bioconductor package for pathway-based data integration and visualization. Bioinformatics. 2013;29(14):1830\u20131.","journal-title":"Bioinformatics"},{"issue":"1","key":"4475_CR36","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3390\/ijms24010358","volume":"24","author":"HOA Elsaid","year":"2022","unstructured":"Elsaid HOA, Tjeldnes H, Rivedal M, Serre C, Eikrem O, Svarstad E, et al. Gene expression analysis in gla-mutant zebrafish reveals enhanced Ca(2+) signaling similar to Fabry disease. Int J Mol Sci. 2022;24(1):358.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4475_CR37","doi-asserted-by":"crossref","first-page":"589","DOI":"10.4161\/auto.6.5.11943","volume":"6","author":"M Chevrier","year":"2010","unstructured":"Chevrier M, Brakch N, Celine L, Genty D, Ramdani Y, Moll S, et al. Autophagosome maturation is impaired in Fabry disease. Autophagy. 2010;6(5):589\u201399.","journal-title":"Autophagy"},{"issue":"2","key":"4475_CR38","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.bbadis.2011.11.001","volume":"1822","author":"GB Biancini","year":"2012","unstructured":"Biancini GB, Vanzin CS, Rodrigues DB, Deon M, Ribas GS, Barschak AG, et al. Globotriaosylceramide is correlated with oxidative stress and inflammation in Fabry patients treated with enzyme replacement therapy. Biochim Biophys Acta. 2012;1822(2):226\u201332.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"4475_CR39","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/jimd.12373","volume":"44","author":"A Schumann","year":"2021","unstructured":"Schumann A, Schaller K, Belche V, Cybulla M, Grunert SC, Moers N, et al. Defective lysosomal storage in Fabry disease modifies mitochondrial structure, metabolism and turnover in renal epithelial cells. J Inherit Metab Dis. 2021;44(4):1039\u201350.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"4475_CR40","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012836","volume":"13","author":"G Parenti","year":"2021","unstructured":"Parenti G, Medina DL, Ballabio A. The rapidly evolving view of lysosomal storage diseases. EMBO Mol Med. 2021;13(2): e12836.","journal-title":"EMBO Mol Med"},{"issue":"4","key":"4475_CR41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/diseases4040031","volume":"4","author":"M de la Mata","year":"2016","unstructured":"de la Mata M, Cotan D, Villanueva-Paz M, de Lavera I, Alvarez-Cordoba M, Luzon-Hidalgo R, et al. Mitochondrial dysfunction in lysosomal storage disorders. Diseases. 2016;4(4):31.","journal-title":"Diseases"},{"issue":"1","key":"4475_CR42","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12944-021-01466-0","volume":"20","author":"M Abed Rabbo","year":"2021","unstructured":"Abed Rabbo M, Khodour Y, Kaguni LS, Stiban J. Sphingolipid lysosomal storage diseases: from bench to bedside. Lipids Health Dis. 2021;20(1):44.","journal-title":"Lipids Health Dis"},{"issue":"5","key":"4475_CR43","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1083\/jcb.201208152","volume":"199","author":"FM Platt","year":"2012","unstructured":"Platt FM, Boland B, van der Spoel AC. The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction. J Cell Biol. 2012;199(5):723\u201334.","journal-title":"J Cell Biol"},{"issue":"4","key":"4475_CR44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/diseases4040035","volume":"4","author":"M Fernandes","year":"2016","unstructured":"Fernandes M, Husi H. Integrative systems biology investigation of fabry disease. Diseases. 2016;4(4):35.","journal-title":"Diseases"},{"issue":"1","key":"4475_CR45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210617","volume":"14","author":"MM Ivanova","year":"2019","unstructured":"Ivanova MM, Changsila E, Iaonou C, Goker-Alpan O. Impaired autophagic and mitochondrial functions are partially restored by ERT in Gaucher and Fabry diseases. PLoS ONE. 2019;14(1): e0210617.","journal-title":"PLoS ONE"},{"key":"4475_CR46","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3389\/fcell.2017.00106","volume":"5","author":"K Todkar","year":"2017","unstructured":"Todkar K, Ilamathi HS, Germain M. Mitochondria and lysosomes: discovering bonds. Front Cell Dev Biol. 2017;5:106.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"4475_CR47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.molmed.2019.10.009","volume":"26","author":"CM Deus","year":"2020","unstructured":"Deus CM, Yambire KF, Oliveira PJ, Raimundo N. Mitochondria-lysosome crosstalk: from physiology to neurodegeneration. Trends Mol Med. 2020;26(1):71\u201388.","journal-title":"Trends Mol Med"},{"key":"4475_CR48","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0065-2423(09)49003-6","volume":"49","author":"AM Das","year":"2009","unstructured":"Das AM, Naim HY. Biochemical basis of Fabry disease with emphasis on mitochondrial function and protein trafficking. Adv Clin Chem. 2009;49:57\u201371.","journal-title":"Adv Clin Chem"},{"issue":"1","key":"4475_CR49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/ijms18010047","volume":"18","author":"C Staudt","year":"2016","unstructured":"Staudt C, Puissant E, Boonen M. Subcellular trafficking of mammalian lysosomal proteins: an extended view. Int J Mol Sci. 2016;18(1):47.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"4475_CR50","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.yexcr.2008.09.020","volume":"315","author":"MS Pols","year":"2009","unstructured":"Pols MS, Klumperman J. Trafficking and function of the tetraspanin CD63. Exp Cell Res. 2009;315(9):1584\u201392.","journal-title":"Exp Cell Res"},{"issue":"21","key":"4475_CR51","doi-asserted-by":"crossref","first-page":"11339","DOI":"10.3390\/ijms222111339","volume":"22","author":"U Jehn","year":"2021","unstructured":"Jehn U, Bayraktar S, Pollmann S, Van Marck V, Weide T, Pavenstadt H, et al. alpha-galactosidase a deficiency in fabry disease leads to extensive dysregulated cellular signaling pathways in human podocytes. Int J Mol Sci. 2021;22(21):11339.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4475_CR52","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0962-8924(03)00005-9","volume":"13","author":"EL Eskelinen","year":"2003","unstructured":"Eskelinen EL, Tanaka Y, Saftig P. At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol. 2003;13(3):137\u201345.","journal-title":"Trends Cell Biol"},{"issue":"4","key":"4475_CR53","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1128\/MCB.01163-08","volume":"29","author":"J Schroder","year":"2009","unstructured":"Schroder J, Lullmann-Rauch R, Himmerkus N, Pleines I, Nieswandt B, Orinska Z, et al. Deficiency of the tetraspanin CD63 associated with kidney pathology but normal lysosomal function. Mol Cell Biol. 2009;29(4):1083\u201394.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"4475_CR54","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ymgme.2013.12.005","volume":"111","author":"A Gonzalez","year":"2014","unstructured":"Gonzalez A, Valeiras M, Sidransky E, Tayebi N. Lysosomal integral membrane protein-2: a new player in lysosome-related pathology. Mol Genet Metab. 2014;111(2):84\u201391.","journal-title":"Mol Genet Metab"},{"issue":"10","key":"4475_CR55","first-page":"1105","volume":"1","author":"RJ Adam","year":"2020","unstructured":"Adam RJ, Paterson MR, Wardecke L, Hoffmann BR, Kriegel AJ. Functionally essential tubular proteins are lost to urine-excreted, large extracellular vesicles during chronic renal insufficiency. Kidney360. 2020;1(10):1105\u201315.","journal-title":"Kidney360."},{"issue":"1","key":"4475_CR56","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1038\/s41598-019-38516-8","volume":"9","author":"C Campos-Silva","year":"2019","unstructured":"Campos-Silva C, Suarez H, Jara-Acevedo R, Linares-Espinos E, Martinez-Pineiro L, Yanez-Mo M, et al. High sensitivity detection of extracellular vesicles immune-captured from urine by conventional flow cytometry. Sci Rep. 2019;9(1):2042.","journal-title":"Sci Rep"},{"key":"4475_CR57","doi-asserted-by":"crossref","unstructured":"Salvi S, Bandini E, Carloni S, Casadio V, Battistelli M, Salucci S, et al. Detection and investigation of extracellular vesicles in serum and urine supernatant of prostate cancer patients. Diagnostics (Basel). 2021;11(3).","DOI":"10.3390\/diagnostics11030466"},{"issue":"6","key":"4475_CR58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157566","volume":"11","author":"OE Bryzgunova","year":"2016","unstructured":"Bryzgunova OE, Zaripov MM, Skvortsova TE, Lekchnov EA, Grigor\u2019eva AE, Zaporozhchenko IA, et al. Comparative study of extracellular vesicles from the urine of healthy individuals and prostate cancer patients. PLoS ONE. 2016;11(6): e0157566.","journal-title":"PLoS ONE"},{"issue":"10","key":"4475_CR59","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/s12276-021-00683-y","volume":"53","author":"JW Kim","year":"2021","unstructured":"Kim JW, Kim HW, Nam SA, Lee JY, Cho HJ, Kim TM, et al. Human kidney organoids reveal the role of glutathione in Fabry disease. Exp Mol Med. 2021;53(10):1580\u201391.","journal-title":"Exp Mol Med"},{"issue":"12","key":"4475_CR60","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1007\/s00415-020-10044-w","volume":"267","author":"C Simoncini","year":"2020","unstructured":"Simoncini C, Torri S, Montano V, Chico L, Gruosso F, Tuttolomondo A, et al. Oxidative stress biomarkers in Fabry disease: is there a room for them? J Neurol. 2020;267(12):3741\u201352.","journal-title":"J Neurol"},{"issue":"6","key":"4475_CR61","doi-asserted-by":"crossref","first-page":"102515","DOI":"10.1016\/j.isci.2021.102515","volume":"24","author":"Q Ding","year":"2021","unstructured":"Ding Q, Zhang Z, Li Y, Liu H, Hao Q, Yang Y, et al. Propionate induces intestinal oxidative stress via Sod2 propionylation in zebrafish. iScience. 2021;24(6):102515.","journal-title":"iScience."},{"issue":"3","key":"4475_CR62","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3727\/096368916X694265","volume":"26","author":"WL Tseng","year":"2017","unstructured":"Tseng WL, Chou SJ, Chiang HC, Wang ML, Chien CS, Chen KH, et al. Imbalanced production of reactive oxygen species and mitochondrial antioxidant SOD2 in Fabry disease-specific human induced pluripotent stem cell-differentiated vascular endothelial cells. Cell Transplant. 2017;26(3):513\u201327.","journal-title":"Cell Transplant"},{"issue":"2","key":"4475_CR63","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.molmed.2016.12.003","volume":"23","author":"N Plotegher","year":"2017","unstructured":"Plotegher N, Duchen MR. Mitochondrial dysfunction and neurodegeneration in lysosomal storage disorders. Trends Mol Med. 2017;23(2):116\u201334.","journal-title":"Trends Mol Med"},{"issue":"8","key":"4475_CR64","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1096\/fj.201701374R","volume":"32","author":"H Maruyama","year":"2018","unstructured":"Maruyama H, Taguchi A, Nishikawa Y, Guili C, Mikame M, Nameta M, et al. Medullary thick ascending limb impairment in the Gla(tm)Tg(CAG-A4GALT) Fabry model mice. FASEB J. 2018;32(8):4544\u201359.","journal-title":"FASEB J"},{"key":"4475_CR65","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijcme.2016.06.002","volume":"12","author":"T Nagano","year":"2016","unstructured":"Nagano T, Nakatsuka S-I, Fujita S, Kanda T, Uematsu M, Ikeda Y, et al. Myocardial fibrosis pathology in Anderson-Fabry disease: evaluation of autopsy cases in the long- and short-term enzyme replacement therapy, and non-therapy case. IJC Metabolic & Endocrine. 2016;12:46\u201351.","journal-title":"IJC Metabolic & Endocrine."},{"issue":"6","key":"4475_CR66","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1073\/pnas.94.6.2540","volume":"94","author":"T Ohshima","year":"1997","unstructured":"Ohshima T, Murray GJ, Swaim WD, Longenecker G, Quirk JM, Cardarelli CO, et al. alpha-Galactosidase A deficient mice: a model of Fabry disease. Proc Natl Acad Sci U S A. 1997;94(6):2540\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"4475_CR67","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ejhf.230","volume":"17","author":"Z Hollander","year":"2015","unstructured":"Hollander Z, Dai DL, Putko BN, Yogasundaram H, Wilson-McManus JE, Thompson RB, et al. Gender-specific plasma proteomic biomarkers in patients with Anderson-Fabry disease. Eur J Heart Fail. 2015;17(3):291\u2013300.","journal-title":"Eur J Heart Fail"},{"key":"4475_CR68","doi-asserted-by":"crossref","first-page":"24329","DOI":"10.1038\/srep24329","volume":"6","author":"C Li","year":"2016","unstructured":"Li C, Tan XF, Lim TK, Lin Q, Gong Z. Comprehensive and quantitative proteomic analyses of zebrafish plasma reveals conserved protein profiles between genders and between zebrafish and human. Sci Rep. 2016;6:24329.","journal-title":"Sci Rep"},{"issue":"1","key":"4475_CR69","volume":"8","author":"W Zheng","year":"2013","unstructured":"Zheng W, Xu H, Lam SH, Luo H, Karuturi RK, Gong Z. Transcriptomic analyses of sexual dimorphism of the zebrafish liver and the effect of sex hormones. PLoS ONE. 2013;8(1): e53562.","journal-title":"PLoS ONE"},{"issue":"4","key":"4475_CR70","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1021\/pr3009226","volume":"12","author":"F Babaei","year":"2013","unstructured":"Babaei F, Ramalingam R, Tavendale A, Liang Y, Yan LS, Ajuh P, et al. Novel blood collection method allows plasma proteome analysis from single zebrafish. J Proteome Res. 2013;12(4):1580\u201390.","journal-title":"J Proteome Res"},{"issue":"D1","key":"4475_CR71","doi-asserted-by":"crossref","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol Y, Bai J, Bandla C, Garcia-Seisdedos D, Hewapathirana S, Kamatchinathan S, et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 2022;50(D1):D543\u201352.","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04475-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04475-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04475-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T09:24:45Z","timestamp":1700299485000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04475-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,5]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4475"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04475-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,5]]},"assertion":[{"value":"8 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Norwegian Food Safety Authority (Mattilsynet) approved the study (FOTS ID 15256). All procedures were performed following the Zebrafish Facility guidelines of the University of Bergen.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not relevant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"591"}}